sight NDC 69779-010

NDC codes

FDA NDC Directory

Product NDC (as listed)69779-010Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69779-0010Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69779-010-01	69779001001	1 BOTTLE in 1 CARTON (69779-010-01) / 29.6 mL in 1 BOTTLEMarketed from Apr 9, 2015

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): sight
Generic name (nonproprietary): aesculus hippocastanum, bud, bromus ramosus, flos, calc fluorica, calc phos, calc sulph, clematis vitalba, flos, ferrum phos, mag phos, nat mur, silicea
Active ingredients: Horse chestnut — 5 [hp_X]/29.6mLBromus ramosus flower — 5 [hp_X]/29.6mLCalcium fluoride — 12 [hp_X]/29.6mLTribasic calcium phosphate — 12 [hp_X]/29.6mLCalcium sulfate anhydrous — 6 [hp_X]/29.6mLClematis vitalba flower — 5 [hp_X]/29.6mLFerrosoferric phosphate — 12 [hp_X]/29.6mLMagnesium phosphate, Dibasic trihydrate — 12 [hp_X]/29.6mLSodium chloride — 6 [hp_X]/29.6mLSilicon dioxide — 12 [hp_X]/29.6mL
Dosage form: Spray
Route: Oral
Labeler: Siddha Flower Essences LLC
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Apr 9, 2015
Listing expires: Dec 31, 2027
Other FDA classes: Calcium (Chemical structure)Calcium (Chemical structure)Divalent (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Increased Coagulation Factor Activity (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Phosphate Chelating Activity (Mechanism)Phosphate Chelating Activity (Mechanism)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers: Product ID 69779-010_474d0a4b-f1e8-401c-e063-6294a90a9cb1SPL ID 474d0a4b-f1e8-401c-e063-6294a90a9cb1SPL set ID e6a5a50f-873e-4aa0-ad66-ccfa70c75cdeUNII 3C18L6RJAZ, 0W9O574LE8, O3B55K4YKI, 91D9GV0Z28, E934B3V59H, 7SCP4N87CI, 91GQH8I5F7, HF539G9L3Q, 451W47IQ8X, ETJ7Z6XBU4UPC 0897186002146
Pharmacologic class: Blood Coagulation Factor; Calculi Dissolution Agent; Osmotic Laxative; Phosphate Binder

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469779001001 followed by a unit qualifier and the quantity

Package 69779-0010-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 31, 2025.

Indications (excerpt from the label)

Uses temporarily relives symptoms of light sensitivity dull vision poor night vision blurred vision after straining eyes repeating same mistakes indications are based on homeopathic materia medica, not clinical tests.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)